Drug Type Small molecule drug |
Synonyms |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Coronary Syndrome | NDA/BLA | China | 30 May 2023 | |
| Ischemic stroke | NDA/BLA | China | 30 May 2023 | |
| Myocardial Infarction | NDA/BLA | China | 30 May 2023 | |
| Thrombosis | NDA/BLA | China | 30 May 2023 | |
| Coronary Artery Disease | Phase 1 | China | 25 Nov 2024 | |
| Atherosclerosis | Phase 1 | China | 19 Dec 2021 |





